News - Panacea Laboratories
GAITHERSBURG, Md., Dec. 11 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. has initiated manufacturing of PC Detect(SM) kits, the Company's diagnostic test for prostate cancer, under GMP conditions.
GAITHERSBURG, Md., Nov. 14 /PRNewswire-FirstCall/ -- Panacea Pharmaceuticals, Inc. announced today that CC Detect(SM), the Company's serum- based colon cancer diagnostic test, is now available from Panacea Laboratories.
GAITHERSBURG, Md., Oct. 17 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. announced today that BC Detect(SM), the Company's serum-based breast cancer diagnostic test, is now available from Panacea Laboratories.
GAITHERSBURG, Md., July 17 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. announced today that LC Detect(sm), the Company's serum-based lung cancer diagnostic test, is now available from Panacea Laboratories.